Welcome Message

Dear Conference Participants and Colleagues,

On behalf of the Organizing Committee, I would like to welcome you to the ninth edition of Antibody Therapeutic Conference (ATC) - 2020 Antibody Therapeutics Conference: Antibody Drug Development in the post-COVID-19 Era and the Strategy of New Generation Antibody Drug Development will be held in the National Biotechnology Research Park (Taipei, Taiwan) on Oct 29th, 2020.

The applications of antibody therapeutics remain a growing field today, especially in the treatment of cancers, immune-mediated diseases and infectious diseases, which all highlighting the critical pharmaceutical importance of antibody therapeutics. Particularly, immunotherapy including antibody-mediated tumor regression, checkpoint blockade, antibody drug conjugates (ADC) and adoptive cell therapy (ACT) acts as potential strategies to cure cancers.

The COVID-19 outbreak in the last quarter of 2019 has posed a major impact on the global economy and society. The industry, government, academia and research institutes worldwide have all invested resources to actively develop diagnostic tests, therapeutic drugs and vaccines for COVID-19. To leverage the achievements so far, this year’s ATC focuses on sharing current development status and drug design concepts of antibody drugs for the treatment of COVID-19 hoping to inspire more ideas for the development of antibody drugs in the post-COVID-19 era.

ATC is an international forum for the field of antibody discovery, antibody engineering, antibody therapeutics development and commercialization with the aim to provide opportunities for the attendants to have good connections and to assist the training and advancement of students, postdoctoral fellows and other new members in the field, in part through sponsorship of international scientific meetings.

Last but not least, we hope the meeting stimulated cross talks between senior experts and young scientists working on antibody therapeutics. This meeting not only provides a forum for sharing your insightful research but also a great opportunity to network with your fellow professionals. We hope this meeting will contribute to the advancement of the field of the antibody therapeutics and you will find this meeting an informative, constructive and inspiring experience.